197 related articles for article (PubMed ID: 36213653)
1. Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease.
Herzog S; Fragkou PC; Arneth BM; Mkhlof S; Skevaki C
Front Med (Lausanne); 2022; 9():979373. PubMed ID: 36213653
[TBL] [Abstract][Full Text] [Related]
2. An intact sialoadhesin (Sn/SIGLEC1/CD169) is not required for attachment/internalization of the porcine reproductive and respiratory syndrome virus.
Prather RS; Rowland RR; Ewen C; Trible B; Kerrigan M; Bawa B; Teson JM; Mao J; Lee K; Samuel MS; Whitworth KM; Murphy CN; Egen T; Green JA
J Virol; 2013 Sep; 87(17):9538-46. PubMed ID: 23785195
[TBL] [Abstract][Full Text] [Related]
3. Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon.
Akiyama H; Ramirez NP; Gibson G; Kline C; Watkins S; Ambrose Z; Gummuluru S
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794041
[TBL] [Abstract][Full Text] [Related]
4. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.
Doehn JM; Tabeling C; Biesen R; Saccomanno J; Madlung E; Pappe E; Gabriel F; Kurth F; Meisel C; Corman VM; Hanitsch LG; Treskatsch S; Heim K; Stegemann MS; Ruwwe-Glösenkamp C; Müller-Redetzky HC; Uhrig A; Somasundaram R; Spies C; von Bernuth H; Hofmann J; Drosten C; Suttorp N; Witzenrath M; Sander LE; Hübner RH
Infection; 2021 Aug; 49(4):757-762. PubMed ID: 33825125
[TBL] [Abstract][Full Text] [Related]
5. Transient Depletion of CD169
Oh DS; Oh JE; Jung HE; Lee HK
Front Immunol; 2017; 8():819. PubMed ID: 28751894
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation.
Kawasaki N; Vela JL; Nycholat CM; Rademacher C; Khurana A; van Rooijen N; Crocker PR; Kronenberg M; Paulson JC
Proc Natl Acad Sci U S A; 2013 May; 110(19):7826-31. PubMed ID: 23610394
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of viral peptide targeting to porcine sialoadhesin using a porcine reproductive and respiratory syndrome virus vaccination-challenge model.
Ooms K; Van Gorp H; Botti S; Van Gaever T; Delputte PL; Nauwynck HJ
Virus Res; 2013 Nov; 177(2):147-55. PubMed ID: 23932898
[TBL] [Abstract][Full Text] [Related]
8. Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169.
Puryear WB; Akiyama H; Geer SD; Ramirez NP; Yu X; Reinhard BM; Gummuluru S
PLoS Pathog; 2013; 9(4):e1003291. PubMed ID: 23593001
[TBL] [Abstract][Full Text] [Related]
9. Research progress on CD169-positive macrophages in tumors.
Hou X; Chen G; Zhao Y
Am J Transl Res; 2021; 13(8):8589-8597. PubMed ID: 34539981
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection.
Xu HC; Huang J; Khairnar V; Duhan V; Pandyra AA; Grusdat M; Shinde P; McIlwain DR; Maney SK; Gommerman J; Löhning M; Ohashi PS; Mak TW; Pieper K; Sic H; Speletas M; Eibel H; Ware CF; Tumanov AV; Kruglov AA; Nedospasov SA; Häussinger D; Recher M; Lang KS; Lang PA
J Virol; 2015 May; 89(9):4748-59. PubMed ID: 25673724
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 up-regulates CD169 (sialoadhesin) expression on monocyte-derived dendritic cells: role in HIV sexual transmission.
De Saint Jean A; Lucht F; Bourlet T; Delézay O
AIDS; 2014 Oct; 28(16):2375-80. PubMed ID: 25354152
[TBL] [Abstract][Full Text] [Related]
12. Tumor Necrosis Factor-Mediated Survival of CD169
Shinde PV; Xu HC; Maney SK; Kloetgen A; Namineni S; Zhuang Y; Honke N; Shaabani N; Bellora N; Doerrenberg M; Trilling M; Pozdeev VI; van Rooijen N; Scheu S; Pfeffer K; Crocker PR; Tanaka M; Duggimpudi S; Knolle P; Heikenwalder M; Ruland J; Mak TW; Brenner D; Pandyra AA; Hoell JI; Borkhardt A; Häussinger D; Lang KS; Lang PA
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142134
[TBL] [Abstract][Full Text] [Related]
13. Sialoadhesin - a macrophage-restricted marker of immunoregulation and inflammation.
O'Neill AS; van den Berg TK; Mullen GE
Immunology; 2013 Mar; 138(3):198-207. PubMed ID: 23181380
[TBL] [Abstract][Full Text] [Related]
14. Sialoadhesin (CD169) expression in CD14+ cells is upregulated early after HIV-1 infection and increases during disease progression.
van der Kuyl AC; van den Burg R; Zorgdrager F; Groot F; Berkhout B; Cornelissen M
PLoS One; 2007 Feb; 2(2):e257. PubMed ID: 17330143
[TBL] [Abstract][Full Text] [Related]
15. Splenic CD163
Yuste M; Fernández-Caballero T; Prieto C; Álvarez B; Martínez-Lobo J; Simarro I; Castro JM; Alonso F; Ezquerra Á; Domínguez J; Revilla C
Vet Microbiol; 2017 Jan; 198():72-80. PubMed ID: 28062010
[TBL] [Abstract][Full Text] [Related]
16. High CD169 Monocyte/Lymphocyte Ratio Reflects Immunophenotype Disruption and Oxygen Need in COVID-19 Patients.
Minutolo A; Petrone V; Fanelli M; Iannetta M; Giudice M; Ait Belkacem I; Zordan M; Vitale P; Rasi G; Sinibaldi-Vallebona P; Sarmati L; Andreoni M; Malergue F; Balestrieri E; Grelli S; Matteucci C
Pathogens; 2021 Dec; 10(12):. PubMed ID: 34959594
[TBL] [Abstract][Full Text] [Related]
17. CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodies.
Akiyama H; Ramirez NG; Gudheti MV; Gummuluru S
PLoS Pathog; 2015 Mar; 11(3):e1004751. PubMed ID: 25760631
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of lymphatic system-specific viral replication and its potential role in autoimmune disease.
Friedrich SK; Lang PA; Friebus-Kardash J; Duhan V; Bezgovsek J; Lang KS
Clin Exp Immunol; 2019 Jan; 195(1):64-73. PubMed ID: 30444956
[TBL] [Abstract][Full Text] [Related]
19. CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy.
Lende SSF; Pahus MH; Monrad I; Olesen R; Mahr AR; Vibholm LK; Østergaard L; Søgaard OS; Andersen AHF; Denton PW; Tolstrup M
Front Cell Infect Microbiol; 2022; 12():919097. PubMed ID: 35865810
[TBL] [Abstract][Full Text] [Related]
20. CD169
Grabowska J; Lopez-Venegas MA; Affandi AJ; den Haan JMM
Front Immunol; 2018; 9():2472. PubMed ID: 30416504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
